Cost effectiveness of pharmacological management for osteoarthritis: a systematic review

J Shi, K Fan, L Yan, Z Fan, F Li, G Wang, H Liu… - … Health Economics and …, 2022 - Springer
Background and objective Osteoarthritis (OA) is a highly prevalent, disabling disease
requiring chronic management that is associated with an enormous individual and societal …

Biological targets of multimolecular therapies in middle-age osteoarthritis

I Andia, L Atilano, N Maffulli - Sports Medicine and Arthroscopy …, 2022 - journals.lww.com
Knee osteoarthritis (OA) is a common condition, prevalent in middle-agedness, associated
with chronic pain and impaired quality of life. Two interrelated biological processes fuel early …

Cost‐Effectiveness of Community‐Based Diet and Exercise for Patients with Knee Osteoarthritis and Obesity or Overweight

PT Kopp, C Yang, H Yang, JN Katz… - Arthritis Care & …, 2024 - Wiley Online Library
Objective Obesity exacerbates pain and functional limitation in persons with knee
osteoarthritis (OA). In the Weight Loss and Exercise for Communities with Arthritis in North …

Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysis

GP Bensen, AC Rogers, VP Leifer, RR Edwards… - Osteoarthritis and …, 2023 - Elsevier
Objective Gabapentin can treat neuropathic pain syndromes and has increasingly been
prescribed to treat nociplastic pain. Some patients with knee osteoarthritis (OA) suffer from …

Depressive symptoms and multi-joint pain partially mediate the relationship between obesity and opioid use in people with knee osteoarthritis

LC Carlesso, SR Jafarzadeh, A Stokes… - Osteoarthritis and …, 2022 - Elsevier
Objectives To assess the relation of obesity to opioid use in people with or at risk of knee
osteoarthritis (OA), and the extent to which this association is mediated by number of painful …

Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer

Y Huang, C Ke, J Cai, X Wei, M Chen, H Sun - Breast Cancer, 2024 - Springer
Background Tamoxifen (TAM) is recommended as the first-line strategy for men with
estrogen receptor (ER)-positive early breast cancer who are candidates for adjuvant …

مقایسه اثر ضد دردي گلوکزامین سولفات با دولوکستین در مبتلایان به استئوآرتریت زانو.

فرانه فرساد, زهرا داودي, ریسا دلکش… - Research in Medicine …, 2023‎ - search.ebscohost.com
Abstract Background and Aim: Osteoarthritis (OA) is a very common painful disease of the
musculoskeletal system. The limitation of the effectiveness of current analgesics had been …

[引用][C] 度洛西汀联合非甾体抗炎药治疗慢性肌肉骨骼疼痛的临床疗效

李思瑶, 赵林, 万成福, 董道松, 宋涛 - 中国医科大学学报, 2022